Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tarsons Products's Enterprise Value is ₹18,986 Mil.
Tarsons Products's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹444 Mil. Therefore, Tarsons Products's EV-to-EBIT ratio for today is 42.72.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Tarsons Products's Enterprise Value is ₹18,986 Mil.
Tarsons Products's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,410 Mil. Therefore, Tarsons Products's EV-to-EBITDA ratio for today is 13.47.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Tarsons Products's Enterprise Value is ₹18,986 Mil.
Tarsons Products's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4,225 Mil. Therefore, Tarsons Products's EV-to-Revenue ratio for today is 4.49.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Tarsons Products (NSE:TARSONS) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Tarsons Products's current Enterprise Value is ₹18,986 Mil.
Tarsons Products's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹444 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Tarsons Products's current Enterprise Value is ₹18,986 Mil.
Tarsons Products's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,410 Mil.
Tarsons Products's current Enterprise Value is ₹18,986 Mil.
Tarsons Products's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,225 Mil.
Tarsons Products's current Enterprise Value is ₹18,986 Mil.
Tarsons Products's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
Tarsons Products's current Enterprise Value is ₹18,986 Mil.
Tarsons Products's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tarsons Products Enterprise Value Related Terms
Tarsons Products Enterprise Value Historical Data
* Premium members only.
The historical data trend for Tarsons Products's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:TARSONS vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Tarsons Products's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tarsons Products Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tarsons Products's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Tarsons Products's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Tarsons Products's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tarsons Products (NSE:TARSONS) has a Enterprise Value of ₹18,986 Mil as of Jul. 18, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Tarsons Products and its competitors.
Is Tarsons Products' Enterprise Value too high?
Tarsons Products' current Enterprise Value is ₹18,986 Mil. Overall, Tarsons Products has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tarsons Products' Enterprise Value compare to ISRG and BDX?
Tarsons Products' Enterprise Value of ₹18,986 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Tarsons Products and its competitors. Tarsons Products's current Enterprise Value is ₹18,986 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsons Products stock overvalued right now?
Based on GuruFocus' analysis, Tarsons Products (NSE:TARSONS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹568.21, compared to a current price of ₹287.45 — trading 49.4% below its estimated fair value. The current Enterprise Value is ₹18,986 Mil. Tarsons Products' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Tarsons Products (NSE:TARSONS), the current Enterprise Value is ₹18,986 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tarsons Products (NSE:TARSONS) Overvalued in 2026?
Based on GuruFocus' analysis, Tarsons Products stock appears to be undervalued.
The current stock price of ₹287.45 is trading 49.4% below its estimated GF Value™ of ₹568.21.
GuruFocus considers Tarsons Products to be Significantly Undervalued.
Key valuation signals for NSE:TARSONS:
Enterprise Value: ₹18,986 Mil
GF Value™: ₹568.21 vs. price of ₹287.45 (49.4% below fair value)
No single metric tells the full story. See the NSE:TARSONS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tarsons Products Ltd is an Indian labware Company engaged in designing, developing, manufacturing, and marketing consumables, reusables, and other including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies, and hospitals. The Company is also engaged in the manufacturing of a wide range of quality labware products that help scientific discovery and improve healthcare. The company generates the majority of its revenue from the sale of manufactured plastic products. Geographically, the company generates the majority of its revenue from India.
82GF Score
Get the complete analysis for NSE:TARSONS
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TARSONS has been successfully added to your 
